Institut Gustave Roussy (IGR) and Dassault Group first joined forces in 2001 around an ambitious and innovative project: creating an in-patient structure specifically dedicated to adolescents suffering from cancer. Until then, these patients were hospitalized in wards intended either for adults or young children.
The adventure continued with the organization of several original fundraising events to support research: Cent Femmes pour la Vie, Cent Hommes pour la Vie, Du Rose pour la Vie.
Since 2007, Dassault Group has contributed to research initiatives targeting a single pathology and a single team of researchers. This system led to a partnership with Prof. Fabrice André a pioneering oncologist and recipient of several international awards for his breast cancer research program “Révolution Cancer.” A world first, this project was designed with the goal of curing more patients more effectively by creating personalized breast cancer protocols.
The research conducted by Prof. André’s teams, with the support of Dassault Group, gave rise to molecular medicine by demonstrating the clinical feasibility of sequencing tumors in women suffering from breast cancer to identify potentially cancer-causing molecular anomalies.